This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
No persistent QOL reduction after chemoradiotherapy for H&N cancer. Pharmacoecon. Outcomes News 208, 10 (1999). https://doi.org/10.1007/BF03274940
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03274940